Provided by Tiger Trade Technology Pte. Ltd.

Novavax

8.94
+0.52006.18%
Post-market: 8.980.0359+0.40%19:59 EDT
Volume:10.45M
Turnover:93.78M
Market Cap:1.47B
PE:-5.89
High:9.20
Open:8.44
Low:8.44
Close:8.42
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:2.21
T/O Rate:7.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-7.71
PE(LYR):3.47

Loading ...

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 11

Novavax Inc. Stock Climbs 5.7%, Outperforms Peers

Dow Jones
·
Mar 10

Novavax Earnings Call Signals Leaner, Partner-Led Future

TIPRANKS
·
Mar 06

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 06

Novavax Inc. Stock Rallies 4.2%, Outperforms Peers

Dow Jones
·
Mar 05

Novavax Inc. Stock Falls 6.1%, Underperforms Peers

Dow Jones
·
Mar 04

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Feb 28

Novavax price target raised to $8 from $7 at BofA

TIPRANKS
·
Feb 27

Novavax Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 27

Novavax price target raised to $16 from $11 at H.C. Wainwright

TIPRANKS
·
Feb 27

Novavax, Inc. : H.c. Wainwright Raises Target Price to $16 From $11

THOMSON REUTERS
·
Feb 27

Novavax Inc. Stock Rises 17.4%, Outperforms Peers

Dow Jones
·
Feb 27

Top Midday Gainers

MT Newswires Live
·
Feb 27

Novavax Shares Surge on Surprise Swing to 4Q Profit

Dow Jones
·
Feb 27

Novavax Rockets 19% as It Raises 2026 Adjusted Revenue Outlook on Strength in Vaccine Deals

Reuters
·
Feb 26

Novavax Shares up 6% After Raising 2026 Adjusted Revenue Outlook

THOMSON REUTERS
·
Feb 26

Novavax Exec Says Co Expects Royalties to Grow Significantly in the 2026-'27 Season Compared to 2025

THOMSON REUTERS
·
Feb 26

Novavax Exec Says Co Sees a Pathway Forward and Ability to Negotiate and Work With the Current Administration

THOMSON REUTERS
·
Feb 26

Novavax CEO Says Current Macro and Regulatory Environment in the United States Pose Significant Uncertainties for Vaccine Companies -Conf Call

THOMSON REUTERS
·
Feb 26

Novavax Exec Says Encouraged by Moderna's Progress With Their Flu Vaccine

THOMSON REUTERS
·
Feb 26